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Abstract
Background: Several inflammatory markers have failed to meet the requirements for an early diagnosis of sepsis in children. Study 
results and trends show that measurement of the combination of biochemical markers offers the best prospects for research on early 
diagnosis of sepsis. Objectives: To evaluate the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) as markers of early 
sepsis in pediatric patients. Methods: All the hospitalized children aged more than 28 days with clinically suspected sepsis, as per the 
definition given by International Pediatric Sepsis Consensus Conference, were selected. The patients were divided into two groups; one 
with culture proven sepsis and the other with culture negative sepsis. CRP and PCT levels were measured at the time of admission and 
48 h after admission. Results: A 40 patients were studied, out of that 15 had culture positive and 25 had culture negative sepsis. The 
mean PCT level was significantly higher at admission than at 48 h after admission, and the mean CRP level was significantly lower at 
admission than at 48 h after admission indicating PCT as early marker of sepsis. Conclusion: CRP and PCT levels have favorable test 
performance in differentiating between culture positive and culture negative sepsis. PCT is earlier to rise compared to CRP and PCT is 
best in predicting the severity followed by CRP.
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Sepsis remains a major cause of mortality and morbidity among the children [1,2]. Clinical experience and various studies have shown that the most important measure in 
reducing the mortality from sepsis is early identification of 
the condition and prompt initiation of therapy [3-6]. However, 
early diagnosis of sepsis in children is difficult in everyday 
practice for many reasons such as variable clinical signs during 
initial period of infection, lag period of 48-72 h in getting 
microbiological culture results and false negative results.
Laboratory tests are as important as physiological 
parameters for the early diagnosis of sepsis. We may be close 
to finding the biological markers that will make the diagnosis 
more objective and more reliable than various clinical signs and 
symptoms. During the last decade, measurement of C-reactive 
protein (CRP) has been added to the set of hematological tests 
(total leukocyte count, neutrophils, and band form counts) that 
have long been used in clinical practice. CRP is an acute phase 
reactant released by the liver after the onset of inflammation or 
tissue damage. This protein is frequently used to differentiate 
between viral and bacterial infections [7,8].
The calcitonin prohormone procalcitonin (PCT) was 
described as a new and innovative parameter of infection 
in 1993. Serum levels are very low in healthy individuals 
(<0.5 ng/ml) which can reach up to 1000 ng/ml in severe 
infections without changes in serum calcitonin levels [9]. Levels 
of PCT rise during bacterial infections but are unchanged during 
viral infections [10-12]. Simon et al. have found that PCT and 
CRP can be used as markers to distinguish bacterial from viral 
infections with PCT having a higher sensitivity and specificity 
than that of CRP (92% vs. 86% and 73% vs. 70%) [13]. We 
planned this study to evaluate the beneficial effects of the 
combination of CRP and PCT to make an early diagnosis of 
sepsis in children.
METHODS
This prospective study was conducted at Indira Gandhi 
Institute of Child Health over a period of 1 year after obtaining 
approval from institutional ethics committee. All the children 
beyond neonatal age presenting with clinical features of sepsis 
and its different spectrum like severe sepsis and septic shock 
were included in the study after obtaining informed consent 
from the parents. Data were collected by taking the history 
and by clinical examination using a systemically designed 
proforma.
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Inclusion Criteria
Children beyond the neonatal age group with suspected sepsis 
in the presence of at least one absolute criterion and additional 
criterion as defined by international pediatric sepsis consensus 
conference [14]. Absolute criteria include: (1) Core temperature 
of >38.5°C or <36°C or, (2) elevated or depressed leukocyte 
count for the age (not secondary to chemotherapy induced 
leukopenia) or >10% immature neutrophils. Additional criteria 
include tachycardia or tachypnea (defined as an increase in 
heart rate and respiratory rate respectively by more than 2 
standard deviations above the values normal for that age).
Exclusion Criteria
Non-infective causes that alter the levels of inflammatory 
markers, such as chronic inflammatory conditions (including 
rheumatoid arthritis, inflammatory bowel disease, and Wilson’s 
disease). Conditions with iron overload whether primary, 
e.g., hereditary hemochromatosis or secondary, e.g., transfusion 
overload, porphyria cutanea tarda, and ineffective erythropoiesis 
(in sideroblastic anemia or thalassemia), and hematological 
malignancy.
Relevant laboratory investigations were done such as 
total white blood cells count, differential count, erythrocyte 
sedimentation rate, platelet count and serial measurements of 
CRP and PCT levels at admission and 48 h after the admission. 
CRP and PCT were performed by using fully automated 
immunoturbidimetric assay. CRP level was considered raised 
if the result was >6 mg/L. PCT level was considered raised if 
the result was >2 ng/ml. Blood culture was performed by using 
agar based growth mediums. The volume of 5 ml of blood was 
collected into bile broth using standard techniques from all the 
patients with clinically suspected sepsis.
Diagnostic accuracy of the test was assessed by using ROC 
curve which denotes the diagnostic performance of a test or the 
accuracy of the test in sepsis cases. Accuracy is measured by 
the area under the ROC curve.
RESULTS
Total 40 cases met the inclusion criteria and were recruited 
in the study. Of these, 42.5% (n=17) cases had fever with 
tachypnoea, 67.5% (n=27) had fever with tachycardia while 
67.5% (n=27) cases had fever and abnormal leukocyte count. 
Hypothermia was not noted in any patient. Clinical and 
demographic details of the study population are presented in 
Table 1. Out of 40 patients, 15 (37.5%) had culture-positive and 
25 (62.5%) had culture-negative sepsis, and these had positive 
findings on clinical examination, imaging and laboratory tests.
Mean age in culture-positive group was 2.04 years while 
in culture-negative group, it was 2.85 years. Mean duration 
of illness was 7.8 and 6.6 days. Out of 40 patients, 17 were 
found to have a septic shock at the time of admission. The most 
common sources of sepsis were pneumonia (n=22) followed 
by urinary tract infection (n=12) and bacterial meningitis 
(n=6). Organisms isolated were Staphylococcus aureus (40%), 
Klebsiella (33%), Escherichia coli (13%), Pneumococci (7%), 
and non-lactose fermenting Gram-negative bacilli (7%).
Mean CRP level at admission (57.5 mg/L) was significantly 
lower (p=0.0074) as compared to mean CRP at 48 h later 
(73.4 mg/L), whereas mean PCT level at 0 h (35.3 ng/ml) was 
significantly higher (p=0.0094) as compared to mean PCT level 
at 48 h after admission (5.6 ng/ml).
The mean CRP level was significantly higher in culture 
positive group compared to culture-negative group at 
admission (p=0.0482) and 48 h after admission (p<0.0001). 
The mean levels of CRP were also significantly higher in septic 
shock group compared to non-septic shock group at admission 
(p=0.0008) and 48 h after admission (p=0.0183). Similarly, 
mean PCT levels were significantly higher in culture positive 
compared to culture-negative group at admission (p=0.0127) 
and 48 h after admission (p=0.0008). Mean PCT levels were 
also significantly higher in septic shock group compared to 
non-septic shock group at 0 and 48 h of admission.
However, total leukocyte count and band cell count were 
not significantly different between culture positive and culture-
negative group at 0 h and 48 h after admission. There was 
also no significant difference in total leukocyte count between 
septic shock and non-septic shock patients at 0 and 48 h after 
admission. Although band cell count was not significantly 
different between septic shock and non-septic shock patients 
(0.1156) at 0 h, it was significantly higher in septic shock group 
compared to non-septic shock group (0.00018) at 48 h after 
admission.
Table 1: Clinical and demographic data of the study population
Clinical and demographic data Culture positive Culture negative p value
Number of patients 15 25
Age - mean (range) 2.04 years (2 months-8 years) 2.85 years (3 months-8 years) 0.34 (NS)
Male:Female ratio 11/4 11/14 0.071 (NS)
Duration of illness mean, (range) 7.8 days (3-15 days) 6.6 days (2-10 days) 0.21 (NS)
Receipt of antibiotics 73.33% (n=11) 68% (n=17) 0.721 (NS)
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As depicted in Table 2, mean PCT levels were significantly 
higher in non-survivors as compared to survivors (p<0.0001). 
However, this difference was not significant in the case of CRP 
levels. Relative risk of mortality for PCT level >2 ng/ml was 
2.77 (p<0.0001) while it was 1.7 (p=0.0027) for CRP level 
>40 mg/L.
Table 3 shows the sensitivity, specificity, positive and 
negative predictive values of different septic markers. The cut-
off value of PCT at >2 ng/ml showed the highest sensitivity, 
specificity, positive as well as negative predictive values.
DISCUSSION
Sepsis remains a major cause of mortality and morbidity among 
children. Several inflammatory markers have failed to meet the 
requirements for an early diagnosis of sepsis. This study shows 
the potential value of measuring the inflammatory markers, 
CRP and PCT in patients with clinically suspected cases of 
sepsis.
CRP, an acute phase protein, was discovered by Tillet 
and Francis in 1930 in patients infected with Streptococcus 
pneumoniae [7]. CRP is synthesized in response to interleukin-6 
which is produced following most of the bacterial infections. 
It is used routinely as a good marker of infection but lacks 
specificity for differentiating between viral and bacterial 
infections. If used alone as a marker, it can result in over 
judicious use of antibiotics. PCT, the prohormone of calcitonin 
was described as a new and innovative parameter of infection 
in 1993 [15]. Its serum levels can reach up to 1000 ng/ml in 
severe infections without changes in serum calcitonin levels, 
which was demonstrated by other authors [16,17]. Same 
authors demonstrated the rapid raise in serum PCT level within 
3 h after injection of endotoxin to the healthy individuals with 
peak levels attaining at 6 h.
We demonstrated that PCT levels were high with a 
sensitivity of 93.3% and specificity of 84% initially which is 
in accordance with the study done by Simon et al. [13]. CRP 
levels were high in a later phase of infection as compared to 
PCT with a sensitivity of 86.6% and specificity of 52% which 
is comparable to the findings of Simon et al. [13]. Mean CRP 
levels at admission were significantly lower as compared to that 
at 48 h. In our study, infection was proven by positive culture 
in 37.5% of the study group. Others had positive findings on 
clinical examination, imaging and laboratory tests. Pavare et al. 
demonstrated 50% positive culture in their study [18].
In our study, we analyzed the acute phase reactants like 
CRP and PCT, total counts and the band forms in differentiating 
between culture positive and culture-negative sepsis at 0 and 
48 h after admission, and also between patients with septic 
shock and non-septic shock at 0 and 48 h after admission. We 
found that both CRP and PCT levels were significantly higher 
in culture positive group than in culture-negative group both at 
the time of admission and 48 h later. Thus, both CRP and PCT 
levels were able to differentiate culture positive and negative 
sepsis.
We also concluded that PCT levels can be used a prognostic 
indicator if children with sepsis as in our study, admission 
PCT levels were significantly higher in non-survivors than in 
survivors. Although CRP could not be able differentiate these 
two groups. Casado-Flores et al. also demonstrated significantly 
higher levels of serum PCT levels in non-survivors than in 
survivors [10]. In our study, Mean CRP level at admission was 
significantly less as compared to levels at 48 h after admission, 
whereas mean PCT level at 0 h was significantly higher than 
the PCT level at 48 h, indicating slower rise of CRP levels than 
PCT levels. Therefore, we can say that PCT can be used as 
a better early marker of sepsis than CRP. These results were 
supported by the study conducted by Carvalho et al. [19].
CONCLUSION
Estimation of inflammatory markers like CRP and PCT can 
help to diagnose sepsis as early as possible and early initiation 
Table 2: Mean PCT and CRP levels of survivor and 
non-survivor group






Non-survivor 7 149.6 103.8 72.6 6.13
Survivor 33 11.14 21.15 54.45 24.68
PCT: Procalcitonin, CRP: C-reactive protein, 
SD: Standard deviation










Total count>15,000/<5000 cells/ul 53.33 24 29.63 46.15 0.176
Band cells>10% 53.3 52 40 65 1.00
CRP>40 mg/L 86.67 52 52 86.67 0.035
PCT>2 ng/ml 93.33 84 77.78 95.45 <0.0001
CRP>40 mg/L, PCT>2 ng/ml 80 84 75 87.5 <0.0001
PCT: Procalcitonin, CRP: C-reactive protein
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of treatment can prevent the mortality and morbidity among 
these children.
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